SUPERNUS PHARMACEUTICALS, INC.

Analyst Reco. Supernus Pharmaceuticals, Inc.

Equities

SUPN

US8684591089

Market Closed - Nasdaq Other stock markets 04:00:00 2024-05-10 pm EDT			5-day change	1st Jan Change
28.96 ^USD	-3.47%		-6.07%	+0.07%

May. 08	Earnings Flash (SUPN) SUPERNUS PHARMACEUTICALS Reports Q1 Revenue $143.6M, vs. Street Est of $145.8M	MT
May. 08	Transcript : Supernus Pharmaceuticals, Inc., Q1 2024 Earnings Call, May 08, 2024

Analyst Reco.

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Supernus Pharmaceuticals Insider Sold Shares Worth $511,677, According to a Recent SEC Filing	Mar. 25	MT
Supernus Pharmaceuticals Insider Sold Shares Worth $436,573, According to a Recent SEC Filing	Mar. 21	MT
Piper Sandler Cuts Price Target on Supernus Pharmaceuticals to $41 From $45, Maintains Overweight Rating	Feb. 28	MT
Piper Sandler Adjusts Price Target on Supernus Pharmaceuticals to $46 From $45, Keeps Overweight Rating	23-05-10	MT
Piper Sandler Adjusts Supernus Pharmaceuticals Price Target to $47 From $40, Maintains Overweight Rating	23-01-23	MT
Piper Sandler Adjusts Price Target on Supernus Pharmaceuticals to $38 From $33, Reiterates Overweight Rating	22-08-31	MT
Jefferies Reinstates Supernus Pharmaceuticals at Buy With $44 Price Target	21-12-01	MT
SUPERNUS PHARMACEUTICALS : Jefferies Lifts Supernus Pharmaceuticals to Buy From Hold, Price Target to $40 From $25	21-04-13	MT
SUPERNUS PHARMACEUTICALS : Piper Sandler Adjusts Supernus Pharmaceuticals PT to $35 From $30, Maintains Overweight Rating	21-02-03	MT
Supernus Pharmaceuticals, Inc. Announces Unaudited Consolidated Earnings Results for the Third Quarter and Nine Months Ended September 30, 2018; Revises Earnings Guidance for the Full Year of 2018; Provides Tax Rate Guidance for the Fourth Quarter of 2018	18-11-06	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.

SIGN UP NOW